[Update on childhood immunization in Switzerland].
The recommendations for routine childhood immunizations undergo continuous re-evaluation and are periodically amended. As a result of the near complete elimination of wild-type poliomyelitis, the oral poliomyelitis live vaccine (OPV) has been replaced by the inactivated vaccine (IPV) for the primary series in infancy. Recent seroepidemiologic data on the dynamics of decay of maternal measles antibodies in infants may lead to the recommendation of administering the first dose of the measles mumps rubella (MMR) vaccine at twelve months rather than at 15 to 23 months of age. The recently introduced hexavalent vaccines for the primary series in infancy provide immunization against hepatitis B without the need for additional injections. Finally, the introduction of pneumococcal conjugate vaccines, which are highly efficacious in infants and young children, will provide the opportunity for successful prevention of vaccine-type invasive pneumococcal infections.
Aebi
C
C
Institut für Infektionskrankheiten und Medizinische Universitäts-Kinderklinik, Universität Bern, Inselspital. christoph.aebi@insel.ch
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D002648:Child; D002675:Child, Preschool; D017325:Hepatitis B Vaccines / Q000008:administration & dosage; D006801:Humans; D007223:Infant; D022542:Measles-Mumps-Rubella Vaccine / Q000008:administration & dosage; D022242:Pneumococcal Vaccines / Q000008:administration & dosage; D011054:Poliovirus Vaccine, Inactivated / Q000008:administration & dosage; D011055:Poliovirus Vaccine, Oral / Q000008:administration & dosage; D012307:Risk Factors; D013557:Switzerland; D014611:Vaccination
D017325:Hepatitis B Vaccines; D022542:Measles-Mumps-Rubella Vaccine; D022242:Pneumococcal Vaccines; D011054:Poliovirus Vaccine, Inactivated; D011055:Poliovirus Vaccine, Oral